nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—MAOA—endogenous depression	0.379	0.477	CbGaD
Methamphetamine—SLC6A4—endogenous depression	0.244	0.307	CbGaD
Methamphetamine—CYP2D6—endogenous depression	0.172	0.216	CbGaD
Methamphetamine—SLC6A2—locus ceruleus—endogenous depression	0.00617	0.0717	CbGeAlD
Methamphetamine—MAOA—locus ceruleus—endogenous depression	0.00569	0.0661	CbGeAlD
Methamphetamine—SLC6A2—sympathetic nervous system—endogenous depression	0.00488	0.0567	CbGeAlD
Methamphetamine—SLC6A2—autonomic nervous system—endogenous depression	0.00328	0.0381	CbGeAlD
Methamphetamine—SLC18A1—adrenal gland—endogenous depression	0.00262	0.0305	CbGeAlD
Methamphetamine—TAAR1—thyroid gland—endogenous depression	0.00238	0.0276	CbGeAlD
Methamphetamine—SLC18A1—endocrine gland—endogenous depression	0.00227	0.0264	CbGeAlD
Methamphetamine—SLC18A1—nervous system—endogenous depression	0.00213	0.0247	CbGeAlD
Methamphetamine—SLC18A1—central nervous system—endogenous depression	0.00205	0.0238	CbGeAlD
Methamphetamine—TAAR1—nervous system—endogenous depression	0.002	0.0232	CbGeAlD
Methamphetamine—TAAR1—central nervous system—endogenous depression	0.00193	0.0224	CbGeAlD
Methamphetamine—SLC18A1—brain—endogenous depression	0.00163	0.0189	CbGeAlD
Methamphetamine—SLC18A2—brainstem—endogenous depression	0.0013	0.0151	CbGeAlD
Methamphetamine—SLC18A2—forebrain—endogenous depression	0.00125	0.0145	CbGeAlD
Methamphetamine—Isocarboxazid—MAOA—endogenous depression	0.00107	0.153	CrCbGaD
Methamphetamine—SLC6A3—brainstem—endogenous depression	0.000981	0.0114	CbGeAlD
Methamphetamine—SLC6A3—forebrain—endogenous depression	0.000947	0.011	CbGeAlD
Methamphetamine—SLC6A4—brainstem—endogenous depression	0.000899	0.0104	CbGeAlD
Methamphetamine—SLC6A4—forebrain—endogenous depression	0.000868	0.0101	CbGeAlD
Methamphetamine—MAOB—brainstem—endogenous depression	0.000855	0.00993	CbGeAlD
Methamphetamine—SLC18A2—adrenal gland—endogenous depression	0.000837	0.00973	CbGeAlD
Methamphetamine—SLC18A2—midbrain—endogenous depression	0.000827	0.00961	CbGeAlD
Methamphetamine—MAOB—forebrain—endogenous depression	0.000825	0.00959	CbGeAlD
Methamphetamine—SLC18A2—thyroid gland—endogenous depression	0.000808	0.00939	CbGeAlD
Methamphetamine—SLC6A2—brainstem—endogenous depression	0.000792	0.0092	CbGeAlD
Methamphetamine—MAOB—adrenal cortex—endogenous depression	0.000765	0.00888	CbGeAlD
Methamphetamine—SLC6A2—forebrain—endogenous depression	0.000764	0.00888	CbGeAlD
Methamphetamine—MAOA—brainstem—endogenous depression	0.000729	0.00848	CbGeAlD
Methamphetamine—SLC18A2—endocrine gland—endogenous depression	0.000726	0.00844	CbGeAlD
Methamphetamine—MAOA—forebrain—endogenous depression	0.000704	0.00818	CbGeAlD
Methamphetamine—MAOB—cardiovascular system—endogenous depression	0.000698	0.00811	CbGeAlD
Methamphetamine—Pargyline—MAOA—endogenous depression	0.000687	0.0988	CrCbGaD
Methamphetamine—SLC18A2—nervous system—endogenous depression	0.00068	0.0079	CbGeAlD
Methamphetamine—SLC18A2—central nervous system—endogenous depression	0.000654	0.0076	CbGeAlD
Methamphetamine—MAOA—adrenal cortex—endogenous depression	0.000652	0.00758	CbGeAlD
Methamphetamine—SLC18A2—cerebellum—endogenous depression	0.00064	0.00743	CbGeAlD
Methamphetamine—ADRA2C—adrenal cortex—endogenous depression	0.000627	0.00729	CbGeAlD
Methamphetamine—SLC6A3—midbrain—endogenous depression	0.000625	0.00727	CbGeAlD
Methamphetamine—MAOB—pituitary gland—endogenous depression	0.000618	0.00718	CbGeAlD
Methamphetamine—SLC22A5—adrenal cortex—endogenous depression	0.000601	0.00698	CbGeAlD
Methamphetamine—Dexfenfluramine—HTR2C—endogenous depression	0.0006	0.0862	CrCbGaD
Methamphetamine—SLC22A3—adrenal gland—endogenous depression	0.000596	0.00693	CbGeAlD
Methamphetamine—MAOA—cardiovascular system—endogenous depression	0.000595	0.00692	CbGeAlD
Methamphetamine—SLC22A3—thyroid gland—endogenous depression	0.000576	0.00669	CbGeAlD
Methamphetamine—SLC6A4—midbrain—endogenous depression	0.000573	0.00666	CbGeAlD
Methamphetamine—MAOB—adrenal gland—endogenous depression	0.000552	0.00641	CbGeAlD
Methamphetamine—MAOB—midbrain—endogenous depression	0.000545	0.00633	CbGeAlD
Methamphetamine—ADRA2A—forebrain—endogenous depression	0.00054	0.00628	CbGeAlD
Methamphetamine—MAOB—thyroid gland—endogenous depression	0.000533	0.00619	CbGeAlD
Methamphetamine—MAOA—pituitary gland—endogenous depression	0.000527	0.00612	CbGeAlD
Methamphetamine—SLC18A2—brain—endogenous depression	0.00052	0.00604	CbGeAlD
Methamphetamine—SLC22A3—endocrine gland—endogenous depression	0.000517	0.00601	CbGeAlD
Methamphetamine—SLC6A3—nervous system—endogenous depression	0.000514	0.00597	CbGeAlD
Methamphetamine—SLC6A2—adrenal gland—endogenous depression	0.000511	0.00594	CbGeAlD
Methamphetamine—ADRA2C—pituitary gland—endogenous depression	0.000507	0.00589	CbGeAlD
Methamphetamine—SLC6A4—endocrine gland—endogenous depression	0.000503	0.00585	CbGeAlD
Methamphetamine—Dexfenfluramine—SLC6A4—endogenous depression	0.000497	0.0715	CrCbGaD
Methamphetamine—SLC6A3—central nervous system—endogenous depression	0.000495	0.00575	CbGeAlD
Methamphetamine—SLC22A5—pituitary gland—endogenous depression	0.000485	0.00564	CbGeAlD
Methamphetamine—SLC22A3—nervous system—endogenous depression	0.000484	0.00562	CbGeAlD
Methamphetamine—SLC6A3—cerebellum—endogenous depression	0.000484	0.00562	CbGeAlD
Methamphetamine—MAOB—endocrine gland—endogenous depression	0.000479	0.00556	CbGeAlD
Methamphetamine—SLC6A4—nervous system—endogenous depression	0.000471	0.00547	CbGeAlD
Methamphetamine—MAOA—adrenal gland—endogenous depression	0.000471	0.00547	CbGeAlD
Methamphetamine—SLC22A3—central nervous system—endogenous depression	0.000466	0.00542	CbGeAlD
Methamphetamine—MAOA—midbrain—endogenous depression	0.000465	0.0054	CbGeAlD
Methamphetamine—MAOA—thyroid gland—endogenous depression	0.000454	0.00528	CbGeAlD
Methamphetamine—SLC6A4—central nervous system—endogenous depression	0.000454	0.00527	CbGeAlD
Methamphetamine—ADRA2C—adrenal gland—endogenous depression	0.000453	0.00526	CbGeAlD
Methamphetamine—MAOB—nervous system—endogenous depression	0.000448	0.0052	CbGeAlD
Methamphetamine—ADRA2C—midbrain—endogenous depression	0.000447	0.00519	CbGeAlD
Methamphetamine—SLC6A2—endocrine gland—endogenous depression	0.000443	0.00515	CbGeAlD
Methamphetamine—SLC22A5—adrenal gland—endogenous depression	0.000434	0.00504	CbGeAlD
Methamphetamine—CYP2D6—brainstem—endogenous depression	0.000433	0.00504	CbGeAlD
Methamphetamine—MAOB—central nervous system—endogenous depression	0.000431	0.00501	CbGeAlD
Methamphetamine—SLC22A5—midbrain—endogenous depression	0.000428	0.00497	CbGeAlD
Methamphetamine—MAOB—cerebellum—endogenous depression	0.000422	0.0049	CbGeAlD
Methamphetamine—SLC22A5—thyroid gland—endogenous depression	0.000418	0.00486	CbGeAlD
Methamphetamine—CYP2D6—forebrain—endogenous depression	0.000418	0.00486	CbGeAlD
Methamphetamine—Phenylpropanolamine—MAOA—endogenous depression	0.000416	0.0598	CrCbGaD
Methamphetamine—SLC6A2—nervous system—endogenous depression	0.000415	0.00482	CbGeAlD
Methamphetamine—MAOA—endocrine gland—endogenous depression	0.000408	0.00474	CbGeAlD
Methamphetamine—ADRA2A—pituitary gland—endogenous depression	0.000404	0.0047	CbGeAlD
Methamphetamine—SLC6A2—central nervous system—endogenous depression	0.000399	0.00464	CbGeAlD
Methamphetamine—SLC6A3—brain—endogenous depression	0.000393	0.00457	CbGeAlD
Methamphetamine—MAOA—nervous system—endogenous depression	0.000382	0.00444	CbGeAlD
Methamphetamine—Phentermine—MAOA—endogenous depression	0.000371	0.0533	CrCbGaD
Methamphetamine—SLC22A3—brain—endogenous depression	0.00037	0.0043	CbGeAlD
Methamphetamine—MAOA—central nervous system—endogenous depression	0.000368	0.00428	CbGeAlD
Methamphetamine—ADRA2C—nervous system—endogenous depression	0.000367	0.00427	CbGeAlD
Methamphetamine—ADRA2A—adrenal gland—endogenous depression	0.000361	0.0042	CbGeAlD
Methamphetamine—SLC6A4—brain—endogenous depression	0.00036	0.00418	CbGeAlD
Methamphetamine—MAOA—cerebellum—endogenous depression	0.00036	0.00418	CbGeAlD
Methamphetamine—ADRA2A—midbrain—endogenous depression	0.000357	0.00414	CbGeAlD
Methamphetamine—ADRA2C—central nervous system—endogenous depression	0.000354	0.00411	CbGeAlD
Methamphetamine—Pseudoephedrine—MAOA—endogenous depression	0.000352	0.0506	CrCbGaD
Methamphetamine—Dexfenfluramine—CYP2D6—endogenous depression	0.000349	0.0502	CrCbGaD
Methamphetamine—ADRA2A—thyroid gland—endogenous depression	0.000349	0.00405	CbGeAlD
Methamphetamine—ADRA2C—cerebellum—endogenous depression	0.000346	0.00402	CbGeAlD
Methamphetamine—Selegiline—MAOA—endogenous depression	0.000343	0.0494	CrCbGaD
Methamphetamine—MAOB—brain—endogenous depression	0.000342	0.00398	CbGeAlD
Methamphetamine—SLC22A5—cerebellum—endogenous depression	0.000331	0.00385	CbGeAlD
Methamphetamine—SLC6A2—brain—endogenous depression	0.000317	0.00368	CbGeAlD
Methamphetamine—ADRA2A—endocrine gland—endogenous depression	0.000313	0.00364	CbGeAlD
Methamphetamine—Phenelzine—MAOA—endogenous depression	0.000302	0.0435	CrCbGaD
Methamphetamine—ADRA2A—nervous system—endogenous depression	0.000293	0.00341	CbGeAlD
Methamphetamine—MAOA—brain—endogenous depression	0.000292	0.00339	CbGeAlD
Methamphetamine—ADRA2A—central nervous system—endogenous depression	0.000282	0.00328	CbGeAlD
Methamphetamine—ADRA2C—brain—endogenous depression	0.000281	0.00326	CbGeAlD
Methamphetamine—ADRA2A—cerebellum—endogenous depression	0.000276	0.00321	CbGeAlD
Methamphetamine—SLC22A5—brain—endogenous depression	0.000269	0.00313	CbGeAlD
Methamphetamine—Phenformin—CYP2D6—endogenous depression	0.000246	0.0353	CrCbGaD
Methamphetamine—CYP2D6—endocrine gland—endogenous depression	0.000243	0.00282	CbGeAlD
Methamphetamine—Phentermine—SLC6A4—endogenous depression	0.000239	0.0344	CrCbGaD
Methamphetamine—CYP2D6—nervous system—endogenous depression	0.000227	0.00264	CbGeAlD
Methamphetamine—Pseudoephedrine—SLC6A4—endogenous depression	0.000227	0.0326	CrCbGaD
Methamphetamine—ADRA2A—brain—endogenous depression	0.000224	0.0026	CbGeAlD
Methamphetamine—CYP2D6—central nervous system—endogenous depression	0.000219	0.00254	CbGeAlD
Methamphetamine—CYP2D6—cerebellum—endogenous depression	0.000214	0.00248	CbGeAlD
Methamphetamine—Amphetamine—SLC6A4—endogenous depression	0.000184	0.0264	CrCbGaD
Methamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.000181	0.00161	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000178	0.00158	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—HTR7—endogenous depression	0.000175	0.00156	CbGpPWpGaD
Methamphetamine—CYP2D6—brain—endogenous depression	0.000174	0.00202	CbGeAlD
Methamphetamine—TAAR1—GPCR ligand binding—HTR2A—endogenous depression	0.000172	0.00153	CbGpPWpGaD
Methamphetamine—MAOA—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000172	0.00152	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—OXT—endogenous depression	0.000171	0.00152	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—CRH—endogenous depression	0.000171	0.00152	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—IL10—endogenous depression	0.00017	0.00151	CbGpPWpGaD
Methamphetamine—Phentermine—CYP2D6—endogenous depression	0.000168	0.0242	CrCbGaD
Methamphetamine—TAAR1—GPCR downstream signaling—HTR1A—endogenous depression	0.000164	0.00146	CbGpPWpGaD
Methamphetamine—Benzyl alcohol—CYP2D6—endogenous depression	0.000162	0.0233	CrCbGaD
Methamphetamine—Dextroamphetamine—CYP2D6—endogenous depression	0.00016	0.0231	CrCbGaD
Methamphetamine—Pseudoephedrine—CYP2D6—endogenous depression	0.000159	0.0229	CrCbGaD
Methamphetamine—TAAR1—GPCR downstream signaling—HTR2C—endogenous depression	0.000159	0.00141	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—CACNB2—endogenous depression	0.000158	0.0014	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000157	0.0014	CbGpPWpGaD
Methamphetamine—Selegiline—CYP2D6—endogenous depression	0.000155	0.0224	CrCbGaD
Methamphetamine—TAAR1—Signaling by GPCR—CRH—endogenous depression	0.000155	0.00138	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—OXT—endogenous depression	0.000155	0.00138	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.00015	0.00134	CbGpPWpGaD
Methamphetamine—SLC18A2—Neuronal System—COMT—endogenous depression	0.000149	0.00133	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HTR1A—endogenous depression	0.000149	0.00133	CbGpPWpGaD
Methamphetamine—SLC18A2—Neuronal System—MAOA—endogenous depression	0.000148	0.00132	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—CACNB2—endogenous depression	0.000147	0.00131	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000146	0.0013	CbGpPWpGaD
Methamphetamine—MAOB—Biological oxidations—POMC—endogenous depression	0.000145	0.00129	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HTR2C—endogenous depression	0.000144	0.00128	CbGpPWpGaD
Methamphetamine—MAOA—Biological oxidations—COMT—endogenous depression	0.000141	0.00125	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000139	0.00124	CbGpPWpGaD
Methamphetamine—Nateglinide—CYP2D6—endogenous depression	0.000139	0.02	CrCbGaD
Methamphetamine—TAAR1—GPCR downstream signaling—HTR7—endogenous depression	0.000139	0.00123	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR ligand binding—POMC—endogenous depression	0.000138	0.00122	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—HTR1A—endogenous depression	0.000132	0.00117	CbGpPWpGaD
Methamphetamine—Amphetamine—CYP2D6—endogenous depression	0.000129	0.0186	CrCbGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000129	0.00115	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HTR7—endogenous depression	0.000126	0.00112	CbGpPWpGaD
Methamphetamine—MAOA—Transmission across Chemical Synapses—COMT—endogenous depression	0.000125	0.00111	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—HTR1A—endogenous depression	0.000123	0.0011	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000123	0.0011	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000123	0.00109	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—WASF2—endogenous depression	0.000119	0.00106	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000118	0.00105	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—COMT—endogenous depression	0.000116	0.00103	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000115	0.00102	CbGpPWpGaD
Methamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000115	0.00102	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000115	0.00102	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—WASF1—endogenous depression	0.000115	0.00102	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000111	0.000983	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—ADM—endogenous depression	0.000109	0.000971	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000109	0.00097	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000105	0.000934	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000104	0.000922	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000102	0.000906	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000101	0.000902	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—HTR1A—endogenous depression	0.0001	0.000891	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—ADM—endogenous depression	9.91e-05	0.000881	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	9.81e-05	0.000872	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—HTR2A—endogenous depression	9.73e-05	0.000865	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	9.69e-05	0.000861	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—COMT—endogenous depression	9.57e-05	0.000851	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	9.47e-05	0.000842	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	9.3e-05	0.000827	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—ADM—endogenous depression	9.26e-05	0.000823	CbGpPWpGaD
Methamphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	9.21e-05	0.000819	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CRH—endogenous depression	9.15e-05	0.000814	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—OXT—endogenous depression	9.15e-05	0.000814	CbGpPWpGaD
Methamphetamine—MAOA—Biological oxidations—POMC—endogenous depression	9.11e-05	0.00081	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	8.98e-05	0.000798	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—COMT—endogenous depression	8.9e-05	0.000791	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	8.88e-05	0.00079	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HTR2A—endogenous depression	8.84e-05	0.000785	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—MAOA—endogenous depression	8.83e-05	0.000785	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR1A—endogenous depression	8.81e-05	0.000783	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR2C—endogenous depression	8.51e-05	0.000756	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—TPH1—endogenous depression	8.37e-05	0.000744	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CRH—endogenous depression	8.31e-05	0.000738	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—OXT—endogenous depression	8.31e-05	0.000738	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	8.3e-05	0.000738	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	8.28e-05	0.000736	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR1A—endogenous depression	8e-05	0.000711	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	7.97e-05	0.000708	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	7.87e-05	0.000699	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—POMC—endogenous depression	7.77e-05	0.000691	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CRH—endogenous depression	7.76e-05	0.00069	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—OXT—endogenous depression	7.76e-05	0.00069	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR2C—endogenous depression	7.72e-05	0.000687	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	7.7e-05	0.000684	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—ADM—endogenous depression	7.52e-05	0.000669	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR1A—endogenous depression	7.47e-05	0.000664	CbGpPWpGaD
Methamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	7.47e-05	0.000664	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR7—endogenous depression	7.45e-05	0.000663	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	7.26e-05	0.000646	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR2C—endogenous depression	7.22e-05	0.000641	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—TPH1—endogenous depression	7.08e-05	0.000629	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—POMC—endogenous depression	7.06e-05	0.000627	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—GATA3—endogenous depression	6.91e-05	0.000614	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	6.78e-05	0.000603	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR7—endogenous depression	6.77e-05	0.000601	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	6.74e-05	0.000599	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—GATA3—endogenous depression	6.45e-05	0.000573	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—TPH2—endogenous depression	6.34e-05	0.000563	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CACNB2—endogenous depression	6.34e-05	0.000563	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR7—endogenous depression	6.32e-05	0.000562	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—OXT—endogenous depression	6.3e-05	0.00056	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CRH—endogenous depression	6.3e-05	0.00056	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—POMC—endogenous depression	6.25e-05	0.000556	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—DPYD—endogenous depression	6.24e-05	0.000554	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	6.22e-05	0.000553	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—COMT—endogenous depression	6.14e-05	0.000545	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—MAOA—endogenous depression	6.09e-05	0.000542	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR1A—endogenous depression	6.07e-05	0.000539	CbGpPWpGaD
Methamphetamine—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	6.05e-05	0.000538	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR2C—endogenous depression	5.86e-05	0.000521	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—POMC—endogenous depression	5.84e-05	0.000519	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	5.81e-05	0.000517	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CACNA1C—endogenous depression	5.8e-05	0.000515	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—ADM—endogenous depression	5.6e-05	0.000498	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	5.51e-05	0.00049	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—TPH2—endogenous depression	5.36e-05	0.000477	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CACNB2—endogenous depression	5.36e-05	0.000477	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—DPYD—endogenous depression	5.28e-05	0.000469	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—TPH1—endogenous depression	5.25e-05	0.000467	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—GATA3—endogenous depression	5.24e-05	0.000466	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—ADM—endogenous depression	5.23e-05	0.000465	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR2A—endogenous depression	5.22e-05	0.000464	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR7—endogenous depression	5.13e-05	0.000456	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—ADM—endogenous depression	5.09e-05	0.000452	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CYP2D6—endogenous depression	5.07e-05	0.00045	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	4.97e-05	0.000442	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CACNA1C—endogenous depression	4.91e-05	0.000436	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—ADM—endogenous depression	4.75e-05	0.000422	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—POMC—endogenous depression	4.74e-05	0.000421	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR2A—endogenous depression	4.74e-05	0.000421	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	4.72e-05	0.00042	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CRH—endogenous depression	4.7e-05	0.000417	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—OXT—endogenous depression	4.7e-05	0.000417	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	4.64e-05	0.000413	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR1A—endogenous depression	4.52e-05	0.000402	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR2A—endogenous depression	4.43e-05	0.000393	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—OXT—endogenous depression	4.39e-05	0.00039	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CRH—endogenous depression	4.39e-05	0.00039	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR2C—endogenous depression	4.37e-05	0.000388	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—TPH1—endogenous depression	4.32e-05	0.000384	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CYP2D6—endogenous depression	4.29e-05	0.000381	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CRH—endogenous depression	4.26e-05	0.000379	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—OXT—endogenous depression	4.26e-05	0.000379	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—ADM—endogenous depression	4.25e-05	0.000378	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR1A—endogenous depression	4.22e-05	0.000375	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—POMC—endogenous depression	4.17e-05	0.000371	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR1A—endogenous depression	4.1e-05	0.000365	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR2C—endogenous depression	4.08e-05	0.000362	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CRH—endogenous depression	3.98e-05	0.000354	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—OXT—endogenous depression	3.98e-05	0.000354	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—TPH2—endogenous depression	3.98e-05	0.000354	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CACNB2—endogenous depression	3.98e-05	0.000354	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—POMC—endogenous depression	3.97e-05	0.000353	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR2C—endogenous depression	3.96e-05	0.000352	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—DPYD—endogenous depression	3.91e-05	0.000348	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—ADM—endogenous depression	3.86e-05	0.000343	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—COMT—endogenous depression	3.84e-05	0.000341	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR1A—endogenous depression	3.83e-05	0.000341	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR7—endogenous depression	3.82e-05	0.00034	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—MAOA—endogenous depression	3.81e-05	0.000339	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—POMC—endogenous depression	3.78e-05	0.000336	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	3.77e-05	0.000335	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR2C—endogenous depression	3.7e-05	0.000329	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CACNA1C—endogenous depression	3.64e-05	0.000323	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR2A—endogenous depression	3.6e-05	0.00032	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR7—endogenous depression	3.57e-05	0.000317	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CRH—endogenous depression	3.56e-05	0.000317	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—OXT—endogenous depression	3.56e-05	0.000317	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—POMC—endogenous depression	3.53e-05	0.000314	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TPH1—endogenous depression	3.51e-05	0.000312	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR7—endogenous depression	3.47e-05	0.000309	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR1A—endogenous depression	3.43e-05	0.000305	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR2C—endogenous depression	3.31e-05	0.000294	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—WASF2—endogenous depression	3.29e-05	0.000292	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—TPH2—endogenous depression	3.27e-05	0.000291	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CACNB2—endogenous depression	3.27e-05	0.000291	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—COMT—endogenous depression	3.25e-05	0.000289	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR7—endogenous depression	3.24e-05	0.000288	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CRH—endogenous depression	3.24e-05	0.000288	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—OXT—endogenous depression	3.24e-05	0.000288	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—MAOA—endogenous depression	3.23e-05	0.000287	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—DPYD—endogenous depression	3.22e-05	0.000286	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CYP2D6—endogenous depression	3.18e-05	0.000283	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—WASF1—endogenous depression	3.15e-05	0.00028	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR1A—endogenous depression	3.11e-05	0.000277	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—WASF2—endogenous depression	3.07e-05	0.000273	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR2C—endogenous depression	3.01e-05	0.000267	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADM—endogenous depression	3.01e-05	0.000267	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CACNA1C—endogenous depression	2.99e-05	0.000266	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—WASF1—endogenous depression	2.94e-05	0.000262	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR7—endogenous depression	2.9e-05	0.000258	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—POMC—endogenous depression	2.87e-05	0.000255	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADM—endogenous depression	2.81e-05	0.00025	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR2A—endogenous depression	2.68e-05	0.000238	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TPH2—endogenous depression	2.66e-05	0.000236	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CACNB2—endogenous depression	2.66e-05	0.000236	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR7—endogenous depression	2.63e-05	0.000234	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CYP2D6—endogenous depression	2.62e-05	0.000233	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—DPYD—endogenous depression	2.61e-05	0.000232	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—OXT—endogenous depression	2.52e-05	0.000224	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CRH—endogenous depression	2.52e-05	0.000224	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR2A—endogenous depression	2.5e-05	0.000222	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—WASF2—endogenous depression	2.49e-05	0.000222	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—POMC—endogenous depression	2.48e-05	0.000221	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR2A—endogenous depression	2.43e-05	0.000216	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CACNA1C—endogenous depression	2.43e-05	0.000216	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR1A—endogenous depression	2.42e-05	0.000216	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—COMT—endogenous depression	2.41e-05	0.000214	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—WASF1—endogenous depression	2.39e-05	0.000212	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—OXT—endogenous depression	2.35e-05	0.000209	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CRH—endogenous depression	2.35e-05	0.000209	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2C—endogenous depression	2.34e-05	0.000208	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TPH1—endogenous depression	2.29e-05	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADM—endogenous depression	2.28e-05	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR2A—endogenous depression	2.27e-05	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR1A—endogenous depression	2.26e-05	0.000201	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2C—endogenous depression	2.19e-05	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—POMC—endogenous depression	2.14e-05	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP2D6—endogenous depression	2.12e-05	0.000189	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—POMC—endogenous depression	2.1e-05	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR7—endogenous depression	2.05e-05	0.000182	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR2A—endogenous depression	2.03e-05	0.000181	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—POMC—endogenous depression	2e-05	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—COMT—endogenous depression	1.98e-05	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MAOA—endogenous depression	1.97e-05	0.000175	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—POMC—endogenous depression	1.94e-05	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR7—endogenous depression	1.92e-05	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CRH—endogenous depression	1.91e-05	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—OXT—endogenous depression	1.91e-05	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR2A—endogenous depression	1.84e-05	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR1A—endogenous depression	1.84e-05	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—POMC—endogenous depression	1.81e-05	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2C—endogenous depression	1.78e-05	0.000158	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TPH2—endogenous depression	1.73e-05	0.000154	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CACNB2—endogenous depression	1.73e-05	0.000154	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—DPYD—endogenous depression	1.7e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—POMC—endogenous depression	1.62e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—COMT—endogenous depression	1.61e-05	0.000143	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MAOA—endogenous depression	1.6e-05	0.000142	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CACNA1C—endogenous depression	1.58e-05	0.000141	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—POMC—endogenous depression	1.56e-05	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR7—endogenous depression	1.56e-05	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—POMC—endogenous depression	1.47e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2A—endogenous depression	1.44e-05	0.000128	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2A—endogenous depression	1.34e-05	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—POMC—endogenous depression	1.28e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—POMC—endogenous depression	1.15e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2A—endogenous depression	1.09e-05	9.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—POMC—endogenous depression	1.07e-05	9.52e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—COMT—endogenous depression	1.05e-05	9.33e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MAOA—endogenous depression	1.04e-05	9.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—POMC—endogenous depression	1.04e-05	9.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—POMC—endogenous depression	8.7e-06	7.74e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—POMC—endogenous depression	6.78e-06	6.03e-05	CbGpPWpGaD
